Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other Non-Current Assets (2017 - 2021)

Cogent Biosciences has reported Other Non-Current Assets over the past 5 years, most recently at $2.0 million for Q3 2021.

  • Quarterly results put Other Non-Current Assets at $2.0 million for Q3 2021, up 62.23% from a year ago — trailing twelve months through Sep 2021 was $2.0 million (up 62.23% YoY), and the annual figure for FY2020 was $1.3 million, changed 0.0%.
  • Other Non-Current Assets for Q3 2021 was $2.0 million at Cogent Biosciences, up from $2.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for COGT hit a ceiling of $2.0 million in Q3 2021 and a floor of $419000.0 in Q4 2018.
  • Median Other Non-Current Assets over the past 5 years was $1.3 million (2018), compared with a mean of $1.3 million.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 69.48% in 2018 and later skyrocketed 199.52% in 2019.
  • Cogent Biosciences' Other Non-Current Assets stood at $1.4 million in 2017, then plummeted by 69.48% to $419000.0 in 2018, then surged by 199.52% to $1.3 million in 2019, then changed by 0.0% to $1.3 million in 2020, then skyrocketed by 62.23% to $2.0 million in 2021.
  • The last three reported values for Other Non-Current Assets were $2.0 million (Q3 2021), $2.0 million (Q2 2021), and $1.3 million (Q1 2021) per Business Quant data.